Provided by Tiger Trade Technology Pte. Ltd.

Glaukos

174.49
-5.2975-2.95%
Volume:377.66K
Turnover:66.37M
Market Cap:10.29B
PE:-53.76
High:179.96
Open:176.86
Low:173.11
Close:179.79
52wk High:191.62
52wk Low:73.16
Shares:58.98M
Float Shares:56.44M
Volume Ratio:0.60
T/O Rate:0.67%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.2456
EPS(LYR):-3.2819
ROE:-25.98%
ROA:-5.18%
PB:15.08
PE(LYR):-53.17

Loading ...

Glaukos (GKOS) Valuation Check As iDose TR Adoption Renews Growth Expectations

Simply Wall St.
·
Jun 10

Analysts Conflicted on These Healthcare Names: Moderna (MRNA) and Glaukos (GKOS)

TIPRANKS
·
Jun 07

Glaukos Shareholders Reinforce Board, Pay and Auditor Support

TIPRANKS
·
Jun 04

Glaukos shareholders elect two directors at annual meeting

Reuters
·
Jun 04

Analyst Reiterates Buy on Glaukos, Citing Long-Term iDose Opportunity and Upcoming Epioxa-Driven Growth

TIPRANKS
·
Jun 03

Glaukos pullback due to concerns about iDose LCD, says William Blair

TIPRANKS
·
May 27

Goldman Sachs Reaffirms Their Buy Rating on Glaukos (GKOS)

TIPRANKS
·
May 26

Steven Lichtman Reiterates Buy on Glaukos, Citing Manageable Coverage Risk and Robust Multiyear iDose Growth Outlook

TIPRANKS
·
May 26

Analysts’ Opinions Are Mixed on These Healthcare Stocks: HUTCHMED (HCM), PepGen Inc. (PEPG) and Glaukos (GKOS)

TIPRANKS
·
May 22

Glaukos: Buy Rating Reiterated as Favorable iDose LCD Eases Reimbursement Overhang and Sets Stage for Epioxa-Driven Growth

TIPRANKS
·
May 22

Glaukos Corp : Btig Raises Target Price to $162 From $141

THOMSON REUTERS
·
May 21

Glaukos Is Maintained at Buy by BTIG

Dow Jones
·
May 21

Glaukos director Gilbert H. Kliman disposes 5,000 common shares for $703,800

Reuters
·
May 19

Glaukos director Gilbert H. Kliman disposes of 5,000 common shares for $675,000

Reuters
·
May 14

Medical Device Stocks Are Ready to Bounce. Two Names to Buy Now. -- Barrons.com

Dow Jones
·
May 14

Glaukos management to speak at Stifel Virtual Ophthalmology Forum

Reuters
·
May 12

Glaukos CFO Alex Thurman disposes 10,000 common shares worth $1.4 million

Reuters
·
May 05

Glaukos President, COO Joseph Gilliam sells 19,573 shares worth $2.81 million

Reuters
·
May 05

Glaukos director Leana Wen sells 1,700 shares for $243,695‬

Reuters
·
May 05

Glaukos Highlights Growth Strategy in Interventional Eye Care

TIPRANKS
·
May 04